Latest Posts

14:41 EDT Wednesday, September 21, 2005

(Business Wire) — BioForm Medical:

Medical Meetings Highlight Radiesse(TM)

— American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) Annual Meeting in Los Angeles, September 22-25, 2005 at the Westin Bonaventure Hotel and Suites

— American Society of Plastic Surgeons’ (ASPS) Annual Meeting in Chicago, September 24-28, 2005 at McCormick Place Lakeside Center

— American Association of Otolaryngology-ENT (AAO) in Los Angeles on September 28, 2005 at the OTO Expo.

—  Landmark HIV Study Reports Significant Improvement in Appearance
of Facial Wasting

Renowned surgeons, Joseph Eviatar, M.D. and Stacey Silvers, M.D. will
unveil the results of a landmark clinical study of 100 patients that
shows the long-lasting effectiveness of Radiesse injections for the
restorative treatment of HIV-associated facial lipoatrophy. 100% of
patients enrolled in one of the largest studies ever reported
significant improvement in their appearance at 6 and 12 months post
treatment. The presentations will be featured at the ASPS and the
AFPRS meetings.

—  Study Confirms Radiesse(TM) Provides Long-term Improvement of
Vocal Fold Insufficiency

Lead investigator and voice specialist, Clark A. Rosen, M.D., will
present his findings of a rigorous clinical study using Radiesse to
treat vocal fold insufficiency at the AAO. Vocal fold insufficiency –
a medical condition in which one or both vocal folds (or cords) lack
the physical capacity to vibrate properly – results in poor voice
quality. More than 100 patients were enrolled in the study with 94% of
them showing improvement in their voice quality six months after
treatment.

—  Radiesse(TM) Lauded As Promising New Treatment Option for Nipple
Reconstruction

Noted plastic surgeon Hilton Becker, M.D., will share his clinical
experience using Radiesse as a non-invasive solution for nipple
projection post-mastectomy, providing patients immediate results and
enhanced self-esteem. In the past, more than 50% nipple reconstruction
surgeries failed over time due to loss of volume. One pilot study
concluded that Radiesse is an ideal soft tissue filler for nipple
reconstruction because of its longevity, biocompatibility and tissue
regenerative properties.

—  Radiesse (TM) Widely Used As Reliable Soft Tissue Filler for
Facial Contouring

Radiesse is gaining popularity among surgeons worldwide as a
long-lasting, non-surgical, biocompatible filler. Radiesse is approved
for facial augmentation in Europe, Latin America and most recently in
Canada. Proven successful cosmetic enhancement includes treatment of
creases or folds between the brows; depressions or sinking under the
eyes; hollowed or sunken-in cheeks; nasolabial folds and lines from
tip of nose to the outer area of lips; laugh lines; jaw line and chin
contouring and acne scarring.

—  Nasal Contouring: The non-surgical “nose job” is a kinder,
gentler alternative for patients who wish to change the shape
of their noses but don’t require full-blown invasive
rhinoplasty.

If you would like to schedule an interview with national experts noted above or with local physicians using Radiesse and their patients, please contact Lisa Diomede at 216.256-7287 or lisadiomede@yahoo.com or Nadine Tosk at 504.453-8344 or nadinepr@bellsouth.net

ND Tosk Communications
Nadine Tosk, 504-453-8344
nadinepr@bellsouth.net

© Business Wire

NEW YORK, NY USA

– Success of Radiesse(TM) Facial Wasting Treatment Trial Means Potential Physical and Psychological Benefits for Many Infected With HIV

NEW YORK, March 22 /PRNewswire/ — Physicians from leading plastic surgery
and dermatology practices report positive results from HIV patients
participating in a clinical trial of Radiesse(TM) synthetic injectable implant
on facial wasting.  The trial is intended to demonstrate the safety and
effectiveness of this widely used tissue augmentation therapy as a treatment
for the facial changes that socially stigmatize many HIV-infected patients.
(Photo:  http://www.newscom.com/cgi-bin/prnh/20050322/LATU049)
Lipoatrophy, or facial wasting, is a condition caused by loss of fat
tissue under the skin of the cheeks resulting in a gaunt appearance.  It is
often associated with the anti-retroviral therapies taken by HIV patients,
and, in some cases, is so severe that patients discontinue therapy.  Radiesse,
developed by BioForm Medical, Inc., is being tested for restoration of facial
volume in patients with Lipoatrophy and to assess patient satisfaction and
improvement in quality of life.  An estimated 150,000 to 350,000 patients may
benefit from such treatment.
“Facial wasting continues to have a debilitating effect on many HIV
patients’ appearance causing them to withdraw from normal social activities,”
stated Stacey L. Silvers, M.D., practicing facial plastic surgeon in New York,
N.Y.  “This new application of Radiesse may provide an immediate and
potentially prolonged effect compared to other available treatments, resulting
in enhanced quality of life.”
The FDA has already approved Radiesse for vocal fold augmentation and
certain plastic surgery reconstruction applications.  It is also being tested
in a trial for the treatment of nasolabial folds.
“I was interested in this study, because I knew of Radiesse’s success in
other tissue bulking uses, and I never questioned its safety,” added Silvers.
“I have found the end results more natural than any other injectable filler on
the market.”
“This product has made a dramatic difference in my life,” noted one of Dr.
Silver’s patients.  “Before participating in the trial, I had become less and
less social because of the hollow appearance of my face.  Now I have new
confidence and a more positive outlook on life.”
“Radiesse seems to be a much-preferred treatment because of its longer
duration over currently available products,” commented Joseph Eviatar, M.D.,
F.A.C.S., of Chelsea Eye & Cosmetic Surgery Associates in New York, NY.
“Patients notice immediate results and require fewer treatments.”
Radiesse is composed of Calcium Hydroxylapatite (“CaHA”) microspheres in a
gel carrier.  CaHA is a naturally occurring material in the body.  “Because
Radiesse is natural in makeup, the product has been proven safe in many
applications and has been well received by patients who are reluctant to
inject non-natural products into their bodies,” added Eviatar.

BioForm Medical, Inc. is a privately held medical device company
developing and commercializing injectable implant products for soft and hard
tissue augmentation.  The company is dedicated to improving patients’ lives by
providing high quality, innovative, safe and effective medical products for
use in the aesthetic plastic surgery and urology markets.  The company’s
corporate headquarters are located in San Mateo, CA, and its R&D and
manufacturing facility is near Milwaukee, WI.  For more information, please
visit http://www.bioformmedical.com

SOURCE BioForm Medical, Inc.

We’re excited to announce the launch of our new website.